Published in Int J Urol on June 01, 2006
Functional genomics identifies therapeutic targets for MYC-driven cancer. Proc Natl Acad Sci U S A (2012) 1.65
Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers. Proc Natl Acad Sci U S A (2013) 1.53
Significance of common variants on human chromosome 8q24 in relation to the risk of prostate cancer in native Japanese men. BMC Genet (2009) 0.87
Synthetic lethal screens as a means to understand and treat MYC-driven cancers. Cold Spring Harb Perspect Med (2014) 0.86
Single-cell genetic analysis reveals insights into clonal development of prostate cancers and indicates loss of PTEN as a marker of poor prognosis. Am J Pathol (2014) 0.82
Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer. PLoS One (2015) 0.82
DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer. Asian J Androl (2016) 0.81
Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancer. Int J Clin Exp Pathol (2015) 0.80
4FISH-IF, a four-color dual-gene FISH combined with p63 immunofluorescence to evaluate NKX3.1 and MYC status in prostate cancer. J Histochem Cytochem (2013) 0.80
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer. Genes Cancer (2014) 0.79
Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer. Sci Rep (2017) 0.75
Mature, adipocyte derived, dedifferentiated fat cells can differentiate into smooth muscle-like cells and contribute to bladder tissue regeneration. J Urol (2009) 1.65
Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy. Eur Urol (2004) 1.64
Retroperitoneoscopic adrenalectomy for adrenal tumors via a single large port. J Endourol (2005) 1.46
A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Jpn J Clin Oncol (2006) 1.13
Multicentric liposarcoma. Int J Urol (2004) 0.97
Expression and regulation of tumor suppressor gene maspin in human bladder cancer. Cancer Lett (2004) 0.92
Quantification of carotenoids in citrus fruit by LC-MS and comparison of patterns of seasonal changes for carotenoids among citrus varieties. J Agric Food Chem (2007) 0.92
Histopathological analysis of angiogenic factors in renal cell carcinoma. Int J Urol (2003) 0.88
Strong significant correlation between MMP-9 and systemic symptoms in patients with localized renal cell carcinoma. Urology (2006) 0.87
Prospective study of estramustine phosphate for hormone refractory prostate cancer patients following androgen deprivation therapy. Urol Int (2005) 0.84
Immunohistochemical and ultrastructural features of neuroendocrine differentiated carcinomas of the prostate: an immunoelectron microscopic study. Ultrastruct Pathol (2005) 0.83
[A case of adrenocortical adenoma coexisting with gastrointestinal stromal tumor]. Hinyokika Kiyo (2007) 0.82
[Case of local recurrence of the periurethral proximal-type epithelioid sarcoma successfully treated by repeated regional excision]. Hinyokika Kiyo (2007) 0.80
Silodosin versus naftopidil for the treatment of benign prostatic hyperplasia: a multicenter randomized trial. Int J Urol (2013) 0.79
Immunosuppressive acidic protein detects high nuclear grade localized renal cell carcinoma. Urology (2005) 0.78
Prostate-specific antigen failure within 2 years of radical prostatectomy predicts overall survival. Int J Urol (2006) 0.78
The impact of angiogenesis on the prognosis of advanced renal cell carcinomas. Hinyokika Kiyo (2004) 0.77
Preoperative management of Cushing's syndrome with metyrapone for severe psychiatric disturbances. Int J Urol (2008) 0.76
Usefulness of contrast-enhanced ultrasound for the diagnosis of recurrent renal cell carcinoma in contralateral kidney. Int J Urol (2006) 0.75
[Hydrocele]. Nihon Rinsho (2002) 0.75
Implications of circulating chromogranin A in prostate cancer. Scand J Urol Nephrol (2007) 0.75
Preparation and antibacterial activity of 3-methyl-1-p-substituted phenylpyrazole-5-thiol. Arch Pharm (Weinheim) (2002) 0.75
Long-term outcome from a study on the prevention of postoperative recurrence in patients with renal cell carcinoma: could PBL be a predictor of postoperative recurrence in patients postoperatively treated with IFN-gamma? Hinyokika Kiyo (2006) 0.75
Image plane positioning by pneumatic actuators for ultrasound guidance. Conf Proc IEEE Eng Med Biol Soc (2013) 0.75
[Adjuvant hormone therapy in patients with positive surgical margins after radical prostatectomy]. Nihon Hinyokika Gakkai Zasshi (2002) 0.75
Chronic contained rupture of an abdominal aortic aneurysm mimicking a retroperitoneal tumor. Hinyokika Kiyo (2007) 0.75
Primary symptomatic perivesical paraganglioma: a case report. Hinyokika Kiyo (2007) 0.75
Pharmacoeconomic analysis of hypertriglyceridemia treatment at medical institutions. Yakugaku Zasshi (2008) 0.75
Long-term survival following radical prostatectomy in Japanese men with clinically localized prostate cancer: a single institutional study. Int J Urol (2004) 0.75
[Acute abducens nerve palsy following prostatitis due to prostate biopsy]. Nihon Hinyokika Gakkai Zasshi (2011) 0.75
Case of seminoma with possible spontaneous regression without extragonadal metastatic lesion. Urology (2007) 0.75
[Surgery for undescended testis]. Nihon Rinsho (2002) 0.75
An accurate calibration method of ultrasound images by center positions of a metal ball. Conf Proc IEEE Eng Med Biol Soc (2012) 0.75
[Enucleation of renal cell carcinoma in von Hippel-Lindau disease using a microwave tissue coagulator]. Hinyokika Kiyo (2004) 0.75
[Varicocele]. Nihon Rinsho (2002) 0.75